ADA’s 2025 Diabetes Guidelines: What’s New for Better Patient Outcomes?

on
December 11, 2024

The American Diabetes Association (ADA) has unveiled its Standards of Care in Diabetes-2025, a comprehensive guide aimed at improving the diagnosis, management, and outcomes of diabetes care. Grounded in the latest research and clinical trials, these guidelines offer actionable strategies to help healthcare professionals deliver optimal care.

Key Updates for Doctors:

Emphasis on Continuous Glucose Monitoring (CGM): Recommended for adults with type 2 diabetes on glucose-lowering agents beyond insulin.

Weight Management Guidance: Advocates for continued use of pharmacotherapy even after achieving weight loss goals, with added insights on GLP-1 receptor agonists for heart and kidney health.

Expanded Nutrition Recommendations: Focus on plant-based proteins, fiber-rich diets, and moderated use of nonnutritive sweeteners to improve metabolic outcomes.

Perioperative Care Enhancements: Guidance on GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists in surgical settings.

Pregnancy-Specific Advice: Identifies potentially harmful medications during pregnancy and offers tailored care modifications.

Liver Disease Treatment: Introduces thyroid hormone receptor-beta agonists for managing metabolic dysfunction-associated steatotic liver disease (MASLD) with liver fibrosis.

Behavioral and Mental Health Focus:

- New protocols for screening fear of hypoglycemia, diabetes distress, and anxiety.

- Refined approaches to improve diabetes care for older adults.

Acute Care Recommendations:

- Updated guidelines for managing diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) in outpatient and inpatient settings.

“The Standards of Care offers the trusted support needed for people living with diabetes and those caring for them to manage the disease and thrive until we find a cure,” said Charles “Chuck” Henderson, CEO of ADA.

The 2025 Standards of Care has received endorsements from leading professional bodies, including the American College of Cardiology and The Obesity Society, further validating its evidence-based approach.